Schroder Investment Management Group Portfolio holdings
AUM
$118B
1-Year Return
26.33%
This Quarter Return
+5.01%
1 Year Return
+26.33%
3 Year Return
+110.68%
5 Year Return
+193.29%
10 Year Return
+454%
AUM
$90.7B
AUM Growth
+$5.66B
(+6.7%)
Cap. Flow
+$2.95B
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
28.95%
Holding
1,307
New
101
Increased
527
Reduced
422
Closed
96
Top Buys
| 1 |
Microsoft
MSFT
|
$288M |
| 2 |
KLA
KLAC
|
$280M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$246M |
| 4 |
Tencent Music
TME
|
$224M |
| 5 |
Elevance Health
ELV
|
$191M |
Top Sells
| 1 |
Intel
INTC
|
$335M |
| 2 |
Vale
VALE
|
$307M |
| 3 |
Eli Lilly
LLY
|
$257M |
| 4 |
Fortinet
FTNT
|
$187M |
| 5 |
First Solar
FSLR
|
$179M |
Sector Composition
| 1 | Technology | 28.68% |
| 2 | Consumer Discretionary | 12.84% |
| 3 | Healthcare | 11.76% |
| 4 | Financials | 11.54% |
| 5 | Communication Services | 11.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Texas Pacific Land
TPL
$20.4B
| $2.96M | ﹤0.01% |
4,025
-724
| -15% | -$532K |
|
827
Fox Class A
FOXA
$27.4B
| $2.95M | ﹤0.01% |
85,716
-8,695
| -9% | -$299K |
|
828
Corbus Pharmaceuticals
CRBP
$121M
| $2.92M | ﹤0.01% |
64,503
| – | – |
|
829
Arvinas
ARVN
$575M
| $2.89M | ﹤0.01% |
108,444
+91,444
| +538% | +$2.43M |
|
830
Royal Caribbean
RCL
$95.7B
| $2.88M | ﹤0.01% |
18,086
+1,036
| +6% | +$165K |
|
831
Essex Property Trust
ESS
$17.3B
| $2.88M | ﹤0.01% |
10,578
+754
| +8% | +$205K |
|
832
Global Payments
GPN
$21.3B
| $2.87M | ﹤0.01% |
29,713
+1,405
| +5% | +$136K |
|
833
Quest Diagnostics
DGX
$20.5B
| $2.84M | ﹤0.01% |
20,777
+1,540
| +8% | +$211K |
|
|
CNH
834
CNH Industrial
CNH
$14.3B
| $2.83M | ﹤0.01% |
278,961
-164,415
| -37% | -$1.67M |
|
835
GE HealthCare
GEHC
$34.6B
| $2.8M | ﹤0.01% |
35,924
+2,913
| +9% | +$227K |
|
836
Boise Cascade
BCC
$3.36B
| $2.74M | ﹤0.01% |
23,012
| – | – |
|
837
Aecom
ACM
$16.8B
| $2.71M | ﹤0.01% |
+30,765
| New | +$2.71M |
|
838
Ionis Pharmaceuticals
IONS
$9.76B
| $2.68M | ﹤0.01% |
56,222
-59,436
| -51% | -$2.83M |
|
839
VICI Properties
VICI
$35.8B
| $2.64M | ﹤0.01% |
92,243
-559
| -0.6% | -$16K |
|
840
DraftKings
DKNG
$23.1B
| $2.55M | ﹤0.01% |
+66,712
| New | +$2.55M |
|
841
Vanguard FTSE Europe ETF
VGK
$26.9B
| $2.54M | ﹤0.01% |
38,010
-115,081
| -75% | -$7.69M |
|
|
BPMC
842
DELISTED
Blueprint Medicines
BPMC
| $2.54M | ﹤0.01% |
23,562
| – | – |
|
843
Trimble
TRMB
$19.2B
| $2.52M | ﹤0.01% |
45,030
+842
| +2% | +$47.1K |
|
844
Zai Lab
ZLAB
$3.42B
| $2.5M | ﹤0.01% |
144,460
| – | – |
|
845
News Corp Class A
NWSA
$16.6B
| $2.44M | ﹤0.01% |
88,465
+17,970
| +25% | +$495K |
|
846
Zimmer Biomet
ZBH
$20.9B
| $2.38M | ﹤0.01% |
21,921
+2,711
| +14% | +$294K |
|
847
Dollar General
DG
$24.1B
| $2.35M | ﹤0.01% |
17,798
+766
| +4% | +$101K |
|
848
Ingersoll Rand
IR
$32.2B
| $2.34M | ﹤0.01% |
25,737
-1,040
| -4% | -$94.5K |
|
849
TransUnion
TRU
$17.5B
| $2.31M | ﹤0.01% |
31,121
-10,379
| -25% | -$770K |
|
850
KB Financial Group
KB
$28.5B
| $2.31M | ﹤0.01% |
40,743
-2,098
| -5% | -$119K |
|